CN101036735A - External-use medicine for dermatosis and its preparation - Google Patents
External-use medicine for dermatosis and its preparation Download PDFInfo
- Publication number
- CN101036735A CN101036735A CN 200710077721 CN200710077721A CN101036735A CN 101036735 A CN101036735 A CN 101036735A CN 200710077721 CN200710077721 CN 200710077721 CN 200710077721 A CN200710077721 A CN 200710077721A CN 101036735 A CN101036735 A CN 101036735A
- Authority
- CN
- China
- Prior art keywords
- acetic acid
- ethanol
- mixed liquor
- portions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an external remedy for dermatosis, belonging to traditional Chinese medicine domain. Its feature lies in that it is composed of 80-120 portions of lycoris radiata, 50-80 portions of borneol, 50-80 portions of menthol, 50-100 portions of camphor, 100-200 portions of southenwood. The ethanol which is 90-95% of the full weight and the acetic acid which is 5-10% of the full weight is equably mixed to obtain ethanol-acetic acid mixed liquor. The lycoris radiata, borneol, menthol, camphor and southenwood are taken according to the above ratio, and then added to the ethanol-acetic acid mixed liquor until the mixed liquor submerges the crude medicines. After closed immersion for 15-20 days and filtrating, the filtrate is just the said external remedy. The invention has features of remarkable therapeutic efficacy, short period of treatment, fast effect, uneasy to recur.
Description
Technical field
The invention belongs to the field of Chinese medicines, relate in particular to the dermopathic medicine for external use of a kind of treatment, also relate to its preparation method simultaneously.
Background technology
Dermatosis is the commonly encountered diseases and the frequently-occurring disease of human body, and wherein tinea is divided into tinea capitis, tinea corporis, tinea manus and pedis, tinea cruris, tinea versicolor, Tinea and microbid etc.Alopecia areata is a kind of patchy alopecia trichopathy of limitation that takes place suddenly.Its lesion scalp is normal, NIP and subjective symptoms.The primary disease course of disease is through slow, but spontaneous remission and recurrence.Neurodermatitis has another name called chronic simple lichen.The traditional Chinese medical science is called neurodermatitis or stubborn dermatitis is a kind of common chronic dermatosis, is feature with skin lichenification and violent pruritus.Main clinical manifestation: primary disease is more common in youth or adult, and the old people is more rare, and the child does not generally fall ill.During onset, pars affecta skin often only has pruritus and does not have the erythra generation.After often scratching or rubbing, just occur the foxtail millet gruel to the Semen phaseoli radiati size to pimple, last for a long time slightly, because of pimple increases day by day, intensive fusion forms that dermatoglyph is deepened and the patch of the typical lichenification that cutaneous ridge swells.Though this type of dermopathic kind of treatment is more at present, effect is not good enough, and very easily recurrence.
Summary of the invention
The object of the present invention is to provide a kind of therapeutic effect significantly, short treating period, instant effect, be difficult for the dermopathic medicine for external use of treatment of recurrence.
Another object of the present invention also is to provide this to treat the preparation method of dermopathic medicine for external use.
The present invention treats dermopathic medicine for external use component and consumption be the inventor according in, doctor trained in Western medicine is clinical dialectical to dermatosis, in conjunction with secret prescription handed down in the family from generation to generation, sum up clinical experience for many years, carry out that a large amount of repetition tests draws, each component and consumption all have better curative effect in the following weight parts scope:
Bulbus Lycoridis Radiatae 80-120 part Borneolum Syntheticum 50-80 part Mentholum 50-80 part
Camphora 50-100 part Herba Artemisiae Annuae 100-200 part.
Preferred each amounts of components is:
50 parts of 50 parts of Mentholums of 100 parts of Borneolum Syntheticums of Bulbus Lycoridis Radiatae
100 parts of 50 portions of Herba Artemisiae Annuaes of Camphora.
The preparation method of the active ingredient of medicine of the present invention comprises the steps:
(1) preparation of ethanol-acetic acid mixed liquor: will account for the ethanol and the acetic acid mix homogeneously that accounts for gross weight 5-10% of gross weight 90-95%, and get ethanol-acetic acid mixed liquor;
(2) take by weighing Bulbus Lycoridis Radiatae, Borneolum Syntheticum, Mentholum, Camphora and Herba Artemisiae Annuae by said ratio, add ethanol-acetic acid mixed liquor, can flood medical material and get final product, sealing was soaked 15-20 days then, filtered, and filtrate promptly.
Medicine for external use of the present invention, selecting natural plant for use is raw material, utilizes the comprehensive function treatment dermatosis of each component, to the human body safe without toxic side effect, free from extraneous odour, and cheap.Show through clinical observation, to various tinea, alopecia, therapeutic effect such as dermatitis significantly, short treating period, instant effect, be difficult for recurrence, have sterilization, antiinflammatory, antipruritic, promote skin metabolism, activate normally immunity of skin, recover the effect of the growth of skin cell tissue.
The specific embodiment
Below clinical observation on the therapeutic effect test by medicine for external use of the present invention further set forth the beneficial effect of medicine of the present invention.
Test example: the clinical observation of the external-use tincture of the embodiment of the invention 1 gained
(1) physical data
Meet alopecia areata alopecia patient 60 examples, the shortest person of the course of disease is 1 year, elder is 12 years; Neurodermatitis patient 60 examples, the shortest person of the course of disease are 1 year, and elder is 10 years; Tinea pedis patient's 200 examples, the shortest person of the course of disease are 1 year, and elder is 13 years.
(2) Therapeutic Method
The alopecia areata alopecia patient is applied in whole scalp position, every day 2-3 time after external-use tincture is exchanged uniform in 1: 1 ratio with cold boiled water; Neurodermatitis is applied in disease sites with external-use tincture, every day 1-2 time; Tinea pedis patient places external-use tincture in the footwear and puts on barefoot, or smears the affected part after the foot bath every night.
(3) efficacy assessment standard
Produce effects: symptomatology is eliminated;
Effectively: cardinal symptom is eliminated substantially;
Invalid: and compare the each side no change or the person of increasing the weight of before the treatment.
(4) therapeutic effect
The sick kind | The example number | Produce effects | Effectively | Invalid | Total effective rate % | |||
The example number | Cure rate % | The example number | Cure rate % | The example number | Cure rate % | |||
Alopecia areata alopecia | 60 | 58 | 96.67 | 2 | 3.33 | 0 | 100 | |
Neurodermatitis | 60 | 60 | 100 | 100 | ||||
Tinea pedis | 200 | 100 | 100 | 100 |
The shortest person treatment course of treatment is 3 months to bald property hair loss patient, and elder is 8 months; The neurodermatitis patient treatment course of treatment, the shortest person was 2 weeks, and elder was 4 weeks; The tinea pedis patient treatment course of treatment, the shortest person was 2 weeks, and elder was 3 weeks.Follow up a case by regular visits to and do not see recurrence in 3 years.
Come further to set forth the preparation method of medicine for external use of the present invention by the following examples.
Embodiment 1:
The preparation method of the tincture of medicine of the present invention comprises the steps:
(1) preparation of ethanol-acetic acid mixed liquor:, get ethanol-acetic acid mixed liquor with 3325kg ethanol and 175kg acetic acid mix homogeneously;
(2) take by weighing Bulbus Lycoridis Radiatae 100kg, Borneolum Syntheticum 50kg, Mentholum 50kg, Camphora 50kg and Herba Artemisiae Annuae 100kg, add ethanol-acetic acid mixed liquor, can flood medical material and get final product, sealing was soaked 15-20 days then, filtered, and filtrate promptly.
Embodiment 2:
The preparation method of the tincture of medicine of the present invention comprises the steps:
(1) preparation of ethanol-acetic acid mixed liquor:, get ethanol-acetic acid mixed liquor with 3510kg ethanol and 390kg acetic acid mix homogeneously;
(2) take by weighing Bulbus Lycoridis Radiatae 80kg, Borneolum Syntheticum 80kg, Mentholum 70kg, Camphora 100kg and Herba Artemisiae Annuae 200kg, add ethanol-acetic acid mixed liquor, can flood medical material and get final product, sealing was soaked 15-20 days then, filtered, and filtrate promptly.
Embodiment 3:
The preparation method of the tincture of medicine of the present invention comprises the steps:
(1) preparation of ethanol-acetic acid mixed liquor:, get ethanol-acetic acid mixed liquor with 3720kg ethanol and 280kg acetic acid mix homogeneously;
(2) take by weighing Bulbus Lycoridis Radiatae 120kg, Borneolum Syntheticum 60kg, Mentholum 80kg, Camphora 80kg and Herba Artemisiae Annuae 150kg, add ethanol-acetic acid mixed liquor, can flood medical material and get final product, sealing was soaked 15-20 days then, filtered, and filtrate promptly.
The above, it only is preferred embodiment of the present invention, be not that the present invention is done any pro forma restriction, any technical solution of the present invention content that do not break away from,, all still belong in the scope of technical solution of the present invention any simple modification, equivalent variations and modification that above embodiment did according to technical spirit of the present invention.
Claims (3)
1, the dermopathic medicine for external use of a kind of treatment is characterized in that it is the medicament of being made by the raw material of following weight parts:
Bulbus Lycoridis Radiatae 80-120 part Borneolum Syntheticum 50-80 part Mentholum 50-80 part
Camphora 50-100 part Herba Artemisiae Annuae 100-200 part.
2, the dermopathic medicine for external use of treatment as claimed in claim 1, wherein the weight proportion of each raw material is:
50 parts of 50 parts of Mentholums of 100 parts of Borneolum Syntheticums of Bulbus Lycoridis Radiatae
100 parts of 50 portions of Herba Artemisiae Annuaes of Camphora.
3, the preparation method of the dermopathic medicine for external use of treatment as claimed in claim 1 or 2 is characterized in that:
(1) preparation of ethanol-acetic acid mixed liquor: will account for the ethanol and the acetic acid mix homogeneously that accounts for gross weight 5-10% of gross weight 90-95%, and get ethanol-acetic acid mixed liquor;
(2) take by weighing Bulbus Lycoridis Radiatae, Borneolum Syntheticum, Mentholum, Camphora and Herba Artemisiae Annuae by said ratio, add ethanol-acetic acid mixed liquor, can flood medical material and get final product, sealing was soaked 15-20 days then, filtered, and filtrate promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100777212A CN100512844C (en) | 2007-04-13 | 2007-04-13 | External-use medicine for dermatosis and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100777212A CN100512844C (en) | 2007-04-13 | 2007-04-13 | External-use medicine for dermatosis and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101036735A true CN101036735A (en) | 2007-09-19 |
CN100512844C CN100512844C (en) | 2009-07-15 |
Family
ID=38888043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100777212A Expired - Fee Related CN100512844C (en) | 2007-04-13 | 2007-04-13 | External-use medicine for dermatosis and its preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100512844C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758418A (en) * | 2015-03-09 | 2015-07-08 | 北京朗程生物科技有限公司 | A foot nursing essence liquid and a preparing method thereof |
CN106798699A (en) * | 2017-03-09 | 2017-06-06 | 葛建华 | A kind of preparation method of mosquito-expelling and antipruritic liquid |
CN107551080A (en) * | 2017-09-21 | 2018-01-09 | 韦忠友 | A kind of phalacrosis prevention and hair generation medicament and preparation method |
CN110237122A (en) * | 2019-06-17 | 2019-09-17 | 雷春明 | A kind of external drug and its preparation method and application |
CN112007125A (en) * | 2019-05-29 | 2020-12-01 | 宋储羽 | A composition for treating dermatoses and its preparation method |
-
2007
- 2007-04-13 CN CNB2007100777212A patent/CN100512844C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758418A (en) * | 2015-03-09 | 2015-07-08 | 北京朗程生物科技有限公司 | A foot nursing essence liquid and a preparing method thereof |
CN106798699A (en) * | 2017-03-09 | 2017-06-06 | 葛建华 | A kind of preparation method of mosquito-expelling and antipruritic liquid |
CN107551080A (en) * | 2017-09-21 | 2018-01-09 | 韦忠友 | A kind of phalacrosis prevention and hair generation medicament and preparation method |
CN112007125A (en) * | 2019-05-29 | 2020-12-01 | 宋储羽 | A composition for treating dermatoses and its preparation method |
CN110237122A (en) * | 2019-06-17 | 2019-09-17 | 雷春明 | A kind of external drug and its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
CN100512844C (en) | 2009-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105395577B (en) | A kind of anti-trioxypurine composition and its preparation | |
CN103463539B (en) | A kind of medicine for the treatment of eczema and its production and use | |
CN101036735A (en) | External-use medicine for dermatosis and its preparation | |
Shi et al. | Insulin and hypertonic glucose in the management of aseptic fat liquefaction of post‐surgical incision: a meta‐analysis and systematic review | |
CN104013878B (en) | A kind of lavipeditum medicine vinegar and preparation method thereof for treating tinea pedis | |
CN101143166B (en) | Medicine for swelling and relieving pain and its preparation method and application | |
WO2015024420A1 (en) | Local anesthesia pain-relieving time-delay agent | |
Feng et al. | Efficacy and safety of Resina Draconis for wound repair in the treatment of diabetic foot ulcer: A systematic review and meta-analysis of randomized controlled trials | |
CN101297814A (en) | Emulsifiable paste for curing acne and preparation thereof | |
CN103142707B (en) | Traditional Chinese medicine paste or treating chronic soft tissue injury and preparation method thereof | |
Ma et al. | Efficacy and safety of Tanreqing injection for cough caused by acute trachea-bronchitis disease: A systematic review and meta-analysis of randomized controlled trials | |
CN105497043B (en) | A kind of externally applied drug and preparation method thereof for treating skin eczema and eczema-like dermatitis | |
CN107875190A (en) | A kind of Chinese medicine preparation essential oil of external curing senile skin itch | |
CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
CN104971349B (en) | A kind of externally used compound preparation | |
WO2016180119A1 (en) | Topical preparation and the use thereof in preparing drugs for treating lumbar disc herniation | |
CN102309631A (en) | Specific poultice for ringworm sores | |
CN106334144A (en) | External use medicine for treating skin diseases | |
CN108392495A (en) | Antipruritic anti-inflammatory ointment | |
CN104873902B (en) | A kind of traditional Chinese medicine plaster for treating wound, osteopathy | |
CN1051003C (en) | Chinese proprietary medicine for curing scalding | |
CN1895348A (en) | Externally-applied medicine | |
ITMI20132157A1 (en) | CORTEXOLONE 17ALFA-PROPIONATE FOR USE IN THE TREATMENT OF SKIN WOUNDS AND / OR ATROPHIC SKIN DISORDERS. 17ALFA CORTEXOLONE-PROPIONED FOR USE IN THE TREATMENT OF SKIN WOUNDS AND / OR ATROPHIC SKIN DISORDERS. | |
CN103860567A (en) | External drug for treating skin diseases and preparation method thereof | |
CN106880670A (en) | A kind of medicine for treating scabies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090715 Termination date: 20120413 |